These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 639067)

  • 21. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
    Vlasov NN; Pliss GB; Balin VV
    Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
    Swaminathan S; Bryan GT
    Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity, carcinogenicity, distribution, and nitroreduction of 4-(5-nitro-2-furyl)thiazole in the rat.
    Swaminathan S; Ertürk E; Bryan GT
    Cancer Res; 1981 Jul; 41(7):2648-53. PubMed ID: 7018666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice.
    Yoshida O; Ertürk E; Bryan GT; Lower GM
    Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Ertürk E; Cohen SM; Price JM; Bryan GT
    Cancer Res; 1969 Dec; 29(12):2219-28. PubMed ID: 5387262
    [No Abstract]   [Full Text] [Related]  

  • 30. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Madarnas P; Elhilali M
    Cancer Res; 1983 Feb; 43(2):617-22. PubMed ID: 6848183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The production of carcinoma of the urinary bladder in rats by feeding N-[3-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Ertürk E; Price JM; Morris JE; Cohen S; Leith RS; Von Esch AM; Crovetti AJ
    Cancer Res; 1967 Nov; 27(11):1998-2002. PubMed ID: 6073497
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer.
    Tiltman AJ
    S Afr Med J; 1972 Mar; 46(11):293-4. PubMed ID: 5018148
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
    Hasegawa R; St John M; Murasaki G; Fukushima S; Cohen SM
    Cancer Lett; 1984 Jan; 21(3):269-75. PubMed ID: 6692345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1974 Mar; 11(5):392-5. PubMed ID: 4815625
    [No Abstract]   [Full Text] [Related]  

  • 39. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and disposition of N-(4-(5-nitro-2-furyl)-(2-14-C)thiazolyl)acetamide in the rat.
    Wang CY; Chiu CW; Bryan GT
    Drug Metab Dispos; 1975; 3(2):89-95. PubMed ID: 236164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.